Recent advances in viral hepatitis.
作者信息
Foster Graham R
机构信息
Queen Mary University of London, Barts and the London School of Medicine.
出版信息
Clin Med (Lond). 2009 Dec;9(6):613-6. doi: 10.7861/clinmedicine.9-6-613.
Abstract
摘要
相似文献
1
Recent advances in viral hepatitis.病毒性肝炎的最新进展
Clin Med (Lond). 2009 Dec;9(6):613-6. doi: 10.7861/clinmedicine.9-6-613.
2
[New aspects in diagnosis and therapy of viral hepatitis].[病毒性肝炎诊断与治疗的新进展]
Internist (Berl). 1992 Sep;33(9):602-9.
3
[Use of serological markers in the diagnosis and prognosis of chronic viral hepatitis].[血清学标志物在慢性病毒性肝炎诊断和预后中的应用]
Rev Invest Clin. 1985 Oct-Dec;37(4):373-83.
4
Viral hepatitis in hospitals--a clinical overview.
J Hosp Infect. 1988 Feb;11 Suppl A:142-9. doi: 10.1016/0195-6701(88)90180-6.
5
Viral hepatitis: expanding the alphabet.病毒性肝炎：字母表不断扩充。
Adv Pediatr. 1999;46:207-43.
6
Viral hepatitis: epidemiology, treatment, prevention.病毒性肝炎：流行病学、治疗与预防
Ethiop Med J. 2008 Apr;46(2):193-200.
7
[Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis].[慢性病毒性肝炎中的抗病毒治疗与肝细胞癌风险]
Ter Arkh. 2013;85(10):94-7.
8
Update hepatitis A-G.更新甲型至庚型肝炎相关内容。
Digestion. 1997;58 Suppl 1:33-6. doi: 10.1159/000201521.
9
[Viral hepatitides].[病毒性肝炎]
Rev Med Suisse Romande. 1989 Nov;109(11):889-99.
10
[Etiology of chronic diffuse liver damages].[慢性弥漫性肝损伤的病因]
Eksp Klin Gastroenterol. 2007(5):36-9, 164.
引用本文的文献
1
Hepatitis C virus; its implication for endodontists.丙型肝炎病毒；其对牙髓病学家的影响。
Iran Endod J. 2014 Summer;9(3):169-73. Epub 2014 Jul 5.
2
Oral conditions associated with hepatitis C virus infection.与丙型肝炎病毒感染相关的口腔状况。
Saudi J Gastroenterol. 2013 Nov-Dec;19(6):245-51. doi: 10.4103/1319-3767.121032.
3
The potential of cytokines as safety biomarkers for drug-induced liver injury.细胞因子作为药物性肝损伤的安全生物标志物的潜力。
Eur J Clin Pharmacol. 2010 Oct;66(10):961-76. doi: 10.1007/s00228-010-0862-x. Epub 2010 Aug 6.
本文引用的文献
1
Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin.居住在英格兰的南亚裔人群中慢性病毒性肝炎的流行情况：在原籍国的流行情况不一定能预测到该人群中的流行情况。
J Viral Hepat. 2010 May;17(5):327-35. doi: 10.1111/j.1365-2893.2009.01240.x. Epub 2009 Dec 9.
2
Community-based treatment for chronic hepatitis C in drug users: high rates of compliance with therapy despite ongoing drug use.社区为吸毒者提供的慢性丙型肝炎治疗：尽管持续吸毒，但治疗的依从率很高。
Aliment Pharmacol Ther. 2009 Jan;29(1):29-37. doi: 10.1111/j.1365-2036.2008.03834.x. Epub 2008 Aug 26.
3
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression.慢性丙型肝炎病毒感染中特定阶段纤维化进展率的估计：一项荟萃分析和荟萃回归
Hepatology. 2008 Aug;48(2):418-31. doi: 10.1002/hep.22375.
4
Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.慢性乙型肝炎病毒感染的无症状患者谷丙转氨酶持续正常时的病毒学和组织学特征
Gastroenterology. 2008 May;134(5):1376-84. doi: 10.1053/j.gastro.2008.02.075. Epub 2008 Feb 29.
5
Hepatitis C in ethnic minority populations in England.英格兰少数族裔人群中的丙型肝炎
J Viral Hepat. 2008 Jun;15(6):421-6. doi: 10.1111/j.1365-2893.2007.00958.x. Epub 2008 Jan 15.
6
Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients.特拉匹韦和聚乙二醇化干扰素-α-2a可抑制患者体内野生型和耐药性1型丙型肝炎病毒的复制。
Hepatology. 2007 Sep;46(3):631-9. doi: 10.1002/hep.21781.
7
Morbidity and mortality in paid Austrian plasma donors infected with hepatitis C at plasma donation in the 1970s.
J Hepatol. 2007 Jul;47(1):31-6. doi: 10.1016/j.jhep.2007.01.023. Epub 2007 Feb 15.
8
Chronic hepatitis B.慢性乙型肝炎
Hepatology. 2007 Feb;45(2):507-39. doi: 10.1002/hep.21513.
9
Pegylated interferon plus ribavirin for chronic hepatitis C: the role of combination therapy today, tomorrow and in the future.
Minerva Gastroenterol Dietol. 2006 Jun;52(2):157-74.
10
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.基于循环乙肝病毒载量水平预测肝硬化风险。
Gastroenterology. 2006 Mar;130(3):678-86. doi: 10.1053/j.gastro.2005.11.016.
Zotero 插件